Quavonlimab (Anti-CTLA-4 / CD152), 1mg*5

Quavonlimab (Anti-CTLA-4 / CD152), 1mg*5

Ralpancizumab (Anti-PCSK9), 1mg

Ralpancizumab (Anti-PCSK9), 1mg

Quavonlimab (Anti-CTLA-4 / CD152), 1mg*25

32.845,19 RON
SKU
SKM_A3020_1mg*25

Quavonlimab (Anti-CTLA-4 / CD152) is a monoclonal antibody targeting the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). It exhibits efficacy in first-line treatment of advanced non-small-cell lung cancer. MW :144.24 KD.

Mai multe informatii
Price 27.601,00 RON (preturile sunt fara TVA)
Description

Quavonlimab (Anti-CTLA-4 / CD152) is a monoclonal antibody targeting the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). It exhibits efficacy in first-line treatment of advanced non-small-cell lung cancer. MW :144.24 KD.